Alamar Biosciences, Inc. — Form 10-Q

Alamar Biosciences executed a Third Amendment to its Loan and Security Agreement with Silicon Valley Bank (a division of First-Citizens Bank Trust Company) on August 6, 2026. The amendment refinances existing Term Loan B Advances and Revolving Line Advances on a cashless basis into a unified $60 million Revolving Line (expandable to $100M via accordion). Key terms: interest at Prime minus 0.50% (floor 6%), maturity July 1, 2029, $150K final payment waiver fee + $25K amendment fee immediately due. Borrower paid $300K prepayment fee waiver and $100K termination fee waiver. No material change to core financial terms; primarily a structural refinancing consolidating prior debt facilities.